Top
Diagnostic Imaging Drug Development Expertise Customized Imaging Endpoints Total Imaging Management Independent Reads and Advanced Image Analysis BRITI Trial Training
Case Studies News Webinars
 
 

Imaging Solutions for Clinical Trials

 

Stop here. Take a breath. Challenges welcome.

 
 
 
fallback.png
 
You need an imaging strategy that's designed and customized for your clinical trial. We're your solution.

When you work with RadMD, we become your in-sourced radiology team. We are first on call for all imaging issues, allowing you to focus on all the other elements of your clinical trial.

 
 

Service Highlights 

laptopstreaks800v2.png
If it's related to medical imaging, we've got you covered.

Imaging Strategy

You need an overall strategy, not just a template. We’ll ensure every detail related to imaging is considered and aligned with your goals.

Customized Image Endpoints

We guide you through the maze of ever-increasing number and complexity of imaging criteria.

Total Imaging Management

We’re not just blinded reads, we manage all imaging aspects from site reads to creating final imaging study reports.

Unique Regulatory Expertise

We are drug developers, and have created and managed imaging IND's and NDA's for more than 50 regulatory authorities.

Image Analysis

Over a decade in developing the largest and best qualified pool of expert image and clinical independent reviewers.

Trial Training - Proprietary Web Portal: BRITI

RadMD’s training arm is the Blinded Reader and Investigator Training Institute (BRITI). More than 1,000 research sites globally trained and qualified.

You need a strategy, not just a template.
 
1,000+

Research sites trained

Site readers and technical training.


600

TRIAL DESIGNS & ANALYSIS

Created imaging endpoints and performed image reviews and analyses.

50+

Regulatory authorities

Submitted IND’s, NDA’s, PMA’s globally.

 
 
 
We're trusted by these organizations worldwide.
 
Client Testimonials

“Guerbet has recently partnered with RadMD for several European, US and Canadian NDA submissions including Lipiodol (diagnostic indication) Lipiodol (therapeutic indication), Dotarem (CNS indication). RadMD has played a critical role in these submissions and approvals. Dr. Kohkan Shamsi led the RadMD team that provided ISS and ISE as well statistical expertise and medical writing  in preparation of these NDA submission. A key contributing factor to this successful collaboration is Dr.Shamsi’s vast experience in contrast agent clinical development and related regulatory issues which has certainly contributed to the success of these projects.”

“Dr. Patt and colleagues at RadMD leave no stone unturned when interrogating imaging data.  Dr. Patt has developed a novel methodology to take the typical RECIST 1.1 analysis and an ordinary CT scan from a clinical trial, and do a deep-dive exploration of the data to maximize the value of an image.  As clinical trials become more focused on the type of therapy, genomics and even the microbiome and less on the origin of the tumor, it will be essential that no data is left behind – every bit of information may be critical. While RadMD is also quite well known for their impressive radiologist training curriculum and radiologists readers, they are carving a new niche for themselves in the clinical trial world.”

“RadMD was hands on with our agent and like a member of our team. They were able to provide us with a customized approach to image assessment based on our agent’s specific MOA. And they were crucial to evaluating the clinical activity of our agent beyond mere RECIST 1.1.”

 
 
Are we a good fit?

We've worked with hundreds of clients and partners over the years, now it's time for us to work together to make your clinical trial a success.

RadMD is the global source for expert physicians to perform independent image and clinical data reviews, patient eligibility, safety and efficacy. Turn-key management of readers (contracts, training, logistic performance monitoring, retraining, etc.) allows sponsors to:
  • Focus on key competencies
  • Save time for the whole team
  • Expedite clinical trial timelines
  • Navigate regulatory and operational needs with confidence